Combined multichannel intraluminal impedance -pH in patients with typical and atypical symptoms refractory to proton pump therapy
Proton pump inhibitor therapy (PPI) has been used for over a decade to successfully treat patients with gastro-oesophageal reflux disease (GORD); however it has been shown that 35-40% of patients with GORD have persistent symptoms on therapy. Combined multichannel intraluminal impedance-pH (MIIpH) i...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2009
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.492036 |